Safety and Efficacy Study of PEA and Polydatin on Intestinal Inflammation and Visceral Hyperalgesia in IBS Patients (CMD-IBS09(2))

This study is currently recruiting participants.
Verified June 2012 by CM&D Pharma Limited
Sponsor:
Information provided by (Responsible Party):
MARIA CRISTINA COMELLI, CM&D Pharma Limited
ClinicalTrials.gov Identifier:
NCT01370720
First received: June 8, 2011
Last updated: June 16, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2013
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)